Viewing Study NCT01266720


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
Study NCT ID: NCT01266720
Status: UNKNOWN
Last Update Posted: 2010-12-24
First Post: 2010-12-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)
Sponsor: Fukushima Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module